Lunai Bioworks Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES, CA, 90067
Mailing Address CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES, CA, 90067
Phone 45 39179840
Fiscal Year End 0630
EIN 452259340
Financial Overview
FY2025
$-0.91
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | December 9, 2025 | View on SEC |
| 8-K Current report of material events | December 3, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 3, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | November 28, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | November 12, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 8-K Current report of material events | November 3, 2025 | View on SEC |
Annual Reports
10-K September 29, 2025
- FDA approved early testing for their cancer drug (pre-clinical phase, 5+ years from market)
- Acquired AI drug-discovery startup Biosymetrics for $6M in stock
Material Events
8-K Financial Distress February 12, 2026
High Impact
- Lunai Bioworks Inc. received a Nasdaq delisting notice due to its stock price falling below the $1.00 minimum bid requirement.
- The company does not qualify for the standard 180-day grace period because it executed a 1-for-10 reverse stock split on September 30, 2025.
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.